share_log

中國中藥:截至二零二四年七月三十一日止月份之股份發行人的證券變動月報表

TRAD CHI MED: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2024

HKEX ·  Aug 2 04:43
Summary by Moomoo AI
中國中藥控股有限公司(股份代號:00570.HK)於2024年8月2日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年7月31日的公司股份變動情況。報告顯示,截至7月底,公司的已發行股份總數維持在5,035,801,852股,本月內沒有增加或減少。同時,公司庫存股份數目為零。報告亦指出,公司股份期權、權證、可換股票據以及其他相關協議或安排在本月內均無變動。該報告由聯席公司秘書趙東吉呈交。
中國中藥控股有限公司(股份代號:00570.HK)於2024年8月2日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年7月31日的公司股份變動情況。報告顯示,截至7月底,公司的已發行股份總數維持在5,035,801,852股,本月內沒有增加或減少。同時,公司庫存股份數目為零。報告亦指出,公司股份期權、權證、可換股票據以及其他相關協議或安排在本月內均無變動。該報告由聯席公司秘書趙東吉呈交。
China Traditional Chinese Medicine Holdings Co., Ltd. (stock code: 00570.HK) submitted the latest monthly report on securities changes to Hong Kong Exchanges and Clearing Limited on August 2, 2024, reporting on the company's share changes as of July 31, 2024. The report shows that as of the end of July, the total number of issued shares of the company remained at 5,035,801,852 shares, without increase or decrease within this month. At the same time, there were no inventory shares of the company. The report also pointed out that there were no changes in the company's share options, warrants, convertible bonds and other related agreements or arrangements in this month. The report was submitted by the joint company secretary Mr. Zhao Dongji.
China Traditional Chinese Medicine Holdings Co., Ltd. (stock code: 00570.HK) submitted the latest monthly report on securities changes to Hong Kong Exchanges and Clearing Limited on August 2, 2024, reporting on the company's share changes as of July 31, 2024. The report shows that as of the end of July, the total number of issued shares of the company remained at 5,035,801,852 shares, without increase or decrease within this month. At the same time, there were no inventory shares of the company. The report also pointed out that there were no changes in the company's share options, warrants, convertible bonds and other related agreements or arrangements in this month. The report was submitted by the joint company secretary Mr. Zhao Dongji.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more